title: Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis.
abstract: BACKGROUND
  Patients with vasospastic (VA) or non vasospastic angina (NVA) without significant coronary stenosis have a reduced risk of infarction but is unclear whether or not this may be attributable to a lack of prothrombotic profile - similar to that present in patients with stable coronary artery disease (CAD).
  
  
  METHODS
  Plasma levels of von Willebrand factor, total and free tissue factor pathway inhibitor, plasminogen activator inhibitor-1, and fibrinogen were analyzed in 15 patients with stable VA and 23 with NVA, all with vasoconstrictive response to acetylcholine although with different severity. Results were compared with those of 20 age-matched controls and 10 patients with CAD.
  
  
  RESULTS
  Plasma levels of von Willebrand factor in patients with VA or NVA were higher than in controls (207 ± 62 and 203 ± 69% vs 121 ± 38%, p < 0.001) and tended to be lower than in CAD patients (264 ± 65, p = 0.145). They also presented higher total tissue factor pathway inhibitor (123 ± 18 and 111 ± 25 vs 88 ± 14, ng/ml p < 0.001) and plasminogen activator inhibitor-1 levels than controls (51 ± 30 and 52 ± 31% vs 19 ± 9 ng/ml, p < 0.001) and similar to CAD patients (134 ± 23 and 62 ± 31, respectively, ns). Moreover, free tissue factor pathway inhibitor plasma levels were lower than controls (18 ± 5 and 17 ± 5 vs 23 ± 8 ng/ml, p = 0.002) and similar to CAD patients (14 ± 5, ns). Despite this prothrombotic condition none of VA or NVA patients presented a myocardial infarction during a 9 year follow-up, an observation also reported in larger series.
  
  
  CONCLUSIONS
  During a stable phase of their disease, patients with VA or NVA present a prothrombotic profile that might eventually contribute to occurrence of myocardial infarction. The rarity of these events, however, may suggests that ill defined factors would protect these patients from coronary plaque rupture/fissure.
authors: Unitat Coronària, Àrea del Cor, Laboratori d'Hemostàsia*, Hospital General Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. 5751jfb@gmail.com.
authors: Jaume
authors: J
authors: Figueras
authors: Jasone
authors: J
authors: Monasterio
authors: Enric
authors: E
authors: Domingo
authors: Beatriz
authors: B
authors: Meneses
authors: Elsa
authors: E
authors: Nieto
authors: Josefa
authors: J
authors: Cortadellas
authors: David
authors: D
authors: Garcia-Dorado
references: Int J Cardiol. 1993 Aug;41(1):21-9
references: 8225669
references: Br Heart J. 1991 Nov;66(5):351-5
references: 1747294
references: N Engl J Med. 1995 Mar 9;332(10):635-41
references: 7845427
references: Circulation. 1999 Jun 8;99(22):2908-13
references: 10359735
references: Circulation. 2002 Feb 5;105(5):546-9
references: 11827916
references: Circulation. 2004 Jun 1;109(21):2518-23
references: 15136498
references: Eur Heart J. 1990 Jun;11(6):525-8
references: 2112469
references: Circulation. 1995 Feb 1;91(3):619-22
references: 7828284
references: Thromb Haemost. 2005 Oct;94(4):787-90
references: 16270631
references: J Am Coll Cardiol. 1995 May;25(6):1310-7
references: 7722126
references: Circulation. 2000 Mar 7;101(9):948-54
references: 10704159
references: N Engl J Med. 1992 Jan 23;326(4):242-50
references: 1727977
references: Blood Coagul Fibrinolysis. 2006 Oct;17(7):527-32
references: 16988546
references: Lancet. 1987 Jul 4;2(8549):3-9
references: 2885513
references: Thromb Res. 2000 Mar 15;97(6):519-23
references: 10704664
references: Circulation. 1987 Jun;75(6):1110-6
references: 3568322
references: Circulation. 2003 Jul 29;108(4):376-7
references: 12885727
references: Am J Cardiol. 2001 Feb 1;87(3):262-6
references: 11165957
references: Am Heart J. 1992 Aug;124(2):314-9
references: 1636575
references: Am J Cardiol. 1988 Jan 1;61(1):77-82
references: 3337020
references: Thromb Haemost. 1998 Mar;79(3):495-9
references: 9531029
references: J Am Coll Cardiol. 1995 Apr;25(5):1013-8
references: 7897110
references: N Engl J Med. 1993 Jun 10;328(23):1659-64
references: 8487824
references: Circulation. 1988 Jul;78(1):1-9
references: 3260150
references: N Engl J Med. 2005 Feb 10;352(6):539-48
references: 15703419
references: Circulation. 2003 Dec 9;108(23):2864-9
references: 14656922
references: J Am Coll Cardiol. 1991 Sep;18(3):801-8
references: 1869744
references: J Am Coll Cardiol. 1986 Mar;7(3):479-83
references: 3512658
references: N Engl J Med. 1999 Jan 14;340(2):115-26
references: 9887164
references: Nutr Metab Cardiovasc Dis. 2003 Dec;13(6):365-71
references: 14979683
references: Lab Invest. 1997 Oct;77(4):291-8
references: 9354763
references: J Am Coll Cardiol. 2000 Dec;36(7):2036-43
references: 11127437
references: J Am Coll Cardiol. 2003 Oct 1;42(7):1149-60
references: 14522472
references: Int J Cardiol. 2003 May;89(1):53-62
references: 12727005
references: Circulation. 1992 Dec;86(6):1864-71
references: 1451258
references: Circulation. 2004 Mar 23;109(11):1343-8
references: 15023872
references: Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):2019-23
references: 10938026
references: J Am Coll Cardiol. 1995 Mar 15;25(4):807-14
references: 7884081
references: Blood. 1998 May 15;91(10):3527-61
references: 9572988
references: Eur Heart J. 1993 Jan;14(1):8-17
references: 8432297
references: Scand J Clin Lab Invest. 2002;62(1):7-13
references: 12002416